Previously identified were a CD44 protein variant or a CD44-SLC1A2 or SLC34A2-ROS1 fusion in cancer tissues.82, 83 Fusion genes are technically difficult to find by next-generation sequencing, and expensive to identify by fluorescence in situ hybridization. The gene discussed is CD44; the disease is cancer.